Management of patients with isolated aortic stenosis considering negative prognostic factors

Background. Aortic stenosis (AS) is the most common valve defect in developed countries; its prevalence increases with age of the population. He most frequent cause for isolated AS in adults is calcification ofnormal tricuspid or congenital bicuspid aortic valve (AV). ’Ete only effective treatment ofAS is aortic valve replacement (AVR). Major negative prognostic factors include low LV ejection fraction (EF), age older than 70, female gender, and comorbidities such as renal dysfunction, chronic obstructive pulmonary disease, and neural disorders. Aim. To study negative prognostic factors influencing outcomes of treatment for AS and to determine possibilities for managing AS patients taking into account these factors. Materials and methods. 120 medical records of patients who had undergone AVR for isolated AS (76 women and 44 men aged 45 to 81) were studied retrospectively, and 50 patients were examined in a late post-AV period (26 women aged 67.5 (65.0-72.0) at the time of surgery, 24 men aged 63.0 (57.0-68.0) at the time of surgery), and 84 unoperated patients (51 women and 33 men). Results. Perioperative death rate was 8.76%, 11 of 120 patients, 3 men (6.8% of operated men) and 8 women (10.5% of all operated women). ’Eie deceased patients aged 70 or older whereas perioperative death rate of patients younger than 70 was zero (Pχ²=0.004). Despite a relatively high perioperative risk, late survival of patients older than 70 who had undergone AVR was substantially and statistically significantly higher than that of unoperated AS patients. In elderly patients who died during the perioperative period of AVR, the history of valve defect was longer, and a part of the patients who did not survive AVR could have been operated at age younger than 70. Unoperated AS patients with a small LV cavity, severe LV hypertrophy, and LV EF >70% were suggested to be isolated into a special group of risk with a special strategy for cardiosurgical treatment.

изолированный аортальный стеноз, фракция изгнания, диастолическая дисфункция, протезирование аортального клапана, Isolated aortic stenosis, ejection fraction, diastolic dysfunction, aortic valve replacement

1. Osnabrugge RLJ, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM et al. Aortic Stenosis in the Elderly. J ournal of the American College of Cardiology. 2013;62(11):1002-12. DOI:10.1016/j.jacc.2013.05.015.

2. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685-94. DOI:10.1016/S1473-3099(05)70267-X.

3. Wallby L, Steffensen T, Jonasson L, Broqvist M. Inflammatory Characteristics of Stenotic Aortic Valves: A Comparison between Rheumatic and Nonrheumatic Aortic Stenosis. Cardiology Research and Practice. 2013;2013:1-7. DOI:10.1155/2013/895215.

4. Bhattacharyya S, Hayward C, Pepper J, Senior R. Risk stratification in asymptomatic severe aortic stenosis: a critical appraisal. European Heart Journal. 2012;33(19):2377-87. DOI:10.1093/ eurheartj/ehs190.

5. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease. Journal of the American College of Cardiology. 2014;63(22):e57-185. DOI:10.1016/ j.jacc.2014.02.536.

6. Караськов А. М., Железнев С. И., Тураев Ф. Ф. Протезирование аортального клапана: прогноз результатов. Патология кровообращения и кардиохирургия. 2010;(1):21-5

7. Goetzenich A, Deppe I, Schnöring H, Gafencu GL, Gafencu D-A, Yildirim H et al. EuroScore 2 for identification of patients for transapical aortic valve replacement - a single center retrospective in 206 patients. Journal of Cardiothoracic Surgery. 2012;7(1):1-7. DOI:10.1186/1749-8090-7-89.

8. Semenovsky ML, Akopov GA, Aniskevich GV, Mekhtiev EK, Tarabarko NN, Belokurov DA. Summary of long term experience in acquired heart diseases surgery. Russian Journal of Transplantology and Artificial Organs. 2014;0(3):39. DOI:10.15825/1995-1191-2014-3-39-44.

9. Трубин В., Николаева Н., Палеева М., Гавдифаттова С. Пожилое население России: проблемы и перспективы. Демография пожилого населения. В: Социальный бюллетень Аналитический центр при правительстве Российской федерации [Интернет]. 2016. с. 5-10

10. Gaudino M. Survival after aortic valve replacement for aortic stenosis: does left ventricular mass regression have a clinical correlate? European Heart Journal. 2004;26(1):51-7. DOI:10.1093/eur-heartj/ehi012.

11. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277-314. DOI:10.1016/j.echo.2016.01.011.

12. Thourani VH, Myung R, Kilgo P, Thompson K, Puskas JD, Lattouf OM et al. Long-Term Outcomes After Isolated Aortic Valve Replacement in Octogenarians: A Modern Perspective. The Annals of Thoracic Surgery. 2008;86(5):1458-65. DOI:10.1016/ j.athoracsur.2008.06.036.

13. Ramaraj R, Sorrell VL. Degenerative aortic stenosis. BMJ. 2008;336(7643):550-5. DOI:10.1136/bmj.39478.498819.AD.

14. Nashef SAM, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR et al. EuroSCORE II. European Journal of Cardio-Thoracic Surgery. 2012;41(4):734-45. DOI:10.1093/ejcts/ezs043.

15. Шматов Д. В., Железнев С. И., Астапов Д. А., Назаров В. М., Кливер Е. Э., Клинкова А. С. и др. Непосредственные результаты протезирования аортального клапана у пациентов с аортальным стенозом и систолической дисфункцией левого желудочка. Патология Кровообращения И Кардиохирургия. 2010;(4):17-22